Teva to pay up to $4.2 billion in U.S. to settle opioid claims | Reuters
Is Teva Pharmaceutical Industries (NYSE:TEVA) A Risky Investment? - Simply Wall St News
Teva Pharmaceutical Industries Ltd. is moving its North American headquarters from North Wales, Mo… | Teva pharmaceuticals, Pharmaceutical industry, Pharmaceutical